Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Journey Through Mucosal Immunity: Cell Trafficking Tales

Huang Tstein

Mucosal immunity stands as the first line of defense against countless pathogens that attempt to breach the body’s delicate interfaces with the external world. This intricate defense system relies on a sophisticated network of immune cells that constantly patrol the mucosal surfaces, ensuring our protection from infections. At the heart of this defense mechanism lies the fascinating phenomenon of cell trafficking—where immune cells traverse the mucosal tissues, seeking out threats and orchestrating immune responses. This abstract offers a glimpse into the captivating world of mucosal immune cell trafficking. It delves into the journeys undertaken by various immune cell populations, such as T cells, B cells, dendritic cells, and macrophages, as they navigate the mucosal landscapes of the respiratory, gastrointestinal, and genitourinary tracts. These tales of cellular migration involve a delicate balance between chemotaxis, adhesion, and immune activation, all orchestrated to maintain mucosal homeostasis. We explore the factors that influence immune cell recruitment to mucosal sites, including the role of chemokines, adhesion molecules, and the microbiota. Additionally, we discuss the challenges posed by pathogens attempting to subvert the mucosal immune system and how immune cells adapt to these threats. Furthermore, this abstract highlights the clinical relevance of understanding mucosal immune cell trafficking, including its implications for vaccine development, the treatment of mucosal infections, and the management of autoimmune diseases.